Status | Study |
Active, not recruiting |
Study Name: Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2012-11-29 Interventions: Drug: gemcitabine hydrochloride |
Recruiting |
Study Name: Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2012-08-14 Interventions: Drug: metformin hydrochloride |
Completed |
Study Name: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy Condition: Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcino Date: 2012-08-03 Interventions: Drug: Akt Inhibitor MK2206 Giv |
Suspended |
Study Name: Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2012-02-14 Interventions: Drug: vismodegib Given PO |
Active, not recruiting |
Study Name: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer Condition: Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcino Date: 2011-01-18 Interventions: Drug: Carboplatin Given IV |
Active, not recruiting |
Study Name: Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2010-11-01 Interventions: Drug: dasatinib Given orally |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery Condition: Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcino Date: 2009-11-13 Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy |
Completed |
Study Name: Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2009-09-21 Interventions: Drug: sorafenib tosylate Given |
Active, not recruiting |
Study Name: GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery Condition: Adult Solid Neoplasm Pancreatic Acinar Cell Carcinoma Date: 2009-04-07 Interventions: Other: Diagnostic Laboratory Biomarker Analysis |
Active, not recruiting |
Study Name: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery Condition: Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcino Date: 2008-04-29 Interventions: Biological: Falimarev Given in |